9788419284303_Abraham_Manual oncología.6ed

CAPÍTULO 11 Cáncer de ano

161

21. Ng M, Leong T, Chander S, et al. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys . 2012;83(5):1455-1462. doi:10.1016/j.ijrobp.2011.12.058 22. Northover JMA, Arnott SJ, Cunningham D, et al. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5- uorouracil, and mitomycin. Lancet . 1996;348(9034):1049-1054. doi:10.1016/S0140-6736(96)03409-5 23. Northover J, Glynne-Jones R, Sebag-Monte ore D, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the rst randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer . 2010;102(7):1123-1128. doi:10.1038/sj.bjc.6605605 24. Ott PA, Piha-Paul SA, Munster P, et al. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal. Ann Oncol . 2017;28(5):1036-1041. doi:10.1093/annonc/mdx029 25. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med . 2011;365(17):1576-1585. doi:10.1056/nejmoa1010971 26. Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometa static cancers: long-term results of the SABR-COMET Phase II randomized trial. J Clin Oncol . 2020;38(25):2830-2838. doi:10.1200/JCO.20.00818 27. Peiffert D, Tournier-Rangeard L, Gérard JP, et al. Induction chemotherapy and dose intensi cation of the radiation boost in locally advanced anal canal carcinoma: nal analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol . 2012;30(16):1941-1948. doi:10.1200/JCO.2011.35.4837 28. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol . 1992;136(1):54-58. doi:10.1093/oxfordjournals.aje.a116420 29. Rao S, Sclafani F, Eng C, et al. International rare cancers initiative multicenter randomized phase II trial of cisplatin and uorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct. J Clin Oncol . 2020;38(22):2510 2518. doi:10.1200/JCO.19.03266 30. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin . 2021;71(1):7-33. doi:10.3322/ caac.21654 31. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal. Results of curative ‐ intent radiation therapy in a series of 270 patients. Cancer . 1994;73(6):1569-1579. doi:10.1002/1097-0142(19940315)73:6<1569:: AID-CNCR2820730607>3.0.CO;2-F SAMPLE